Jefferies Financial Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Jefferies Financial Group's DGX Position: Q3 2026 in Review
Jefferies Financial Group reduced its Quest Diagnostics (DGX) stake by 90% in Q3 2026, selling an estimated $3.6M and leaving 1,781 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.
Jefferies Financial Group first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.12M in Q2 2024. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Jefferies Financial Group held 1,781 shares of Quest Diagnostics worth $415K as of Q3 2026.
- Jefferies Financial Group sold 15,594 Quest Diagnostics shares in Q3 2026, an estimated $3.6M.
- Quest Diagnostics made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1011 holding.
- Jefferies Financial Group first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
- Jefferies Financial Group's Quest Diagnostics position peaked at $8.12M in Q2 2024.
- 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.